openPR Logo
Press release

2 of Global TOP 10 Biopharma companies selected REGai for Regulatory Automation

04-28-2020 12:00 PM CET | Health & Medicine

Press release from: DDismart

2 of Global TOP 10 Biopharma companies selected REGai for Regulatory Automation
DDi is a leading Automation & AI solution provider for Life sciences industry. REGai is touted to manage various aspects of Regulatory affairs, Submissions/Publishing, CMC and Regulatory Writing and considered as distinct way out for all the regulatory automation requirements.
Experience the automation & cognitive Era with REGai
REGai is selected by two global top 10 pharma companies to assist several functional areas. Primary objectives of these sponsors to use REGai include efficiency gains, time reduction and cost savings.
REGai addressing these challenges:
Single platform
REGai platform as a foundation can be leveraged to automate several functions and activities in Regulatory Operations, Regulatory Affairs, Regulatory Writing and CMC, enabling the orchestration of all means of modern work -- humans and bots complimenting each other.
Improves performance Efficacy and measurable Outcome
Measurable outcomes and improved efficiency have been two of the main reasons in selecting REGai for automation. Automated systems characteristically execute the current processes with less intervention, ensuring better control and reliability of quality. Also, augmented process control makes more ingenious use of existing teams, ensuring fewer errors/issues.
Maintaining regulatory compliance

Automated Regulatory in place helps global regulatory affairsand operations ensure compliance by embedding required controls & country specific requirements in REGai at different stages. It will facilitate your products on the market by executing proactive compliance andspeeding up new market approvals.

About DDi:
DDi is a prominent Technology partner dedicated 100% to the Life Sciences industry. DDi has built its solution competency with a unique blend of Technical and life sciences domain expertise to serve the technology needs of global clients. We provide smarter technology for Clinical Development and Regulatory domains. Our customer base includes organizations from global Top 100 life science companies to small & mid-size manufacturers.

New Jersey (HQ)
4 Independence Way
Suite 110
Princeton, NJ 08540
Tel: (877) 877-1519

DDi is a prominent Technology partner to the Life Sciences industry. DDi has built its solution competency with a unique blend of functional and domain expertise to serve the technology needs of global clients. We provide smarter technology for Clinical Development, Regulatory and Safety domains by providing innovative technology products and solutions for organizations of various sizes. Our customer base includes organizations from global Top 100 life science companies to small & mid-size manufacturers. DDi is a Makro Company.

Smart Products

DDi portfolio includes products in regulatory & compliance areas. By focusing on "smart" features, DDi provides cost-effective and robust IT products. Our products & solutions are validated following 21 CFR Part 11 standards and support several other regulatory guidelines.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2 of Global TOP 10 Biopharma companies selected REGai for Regulatory Automation here

News-ID: 2026635 • Views: